Literature DB >> 19595951

Neuropsychological testing and assessment for dementia.

Claudia Jacova1, Andrew Kertesz, Mervin Blair, John D Fisk, Howard H Feldman.   

Abstract

This evidence-based review examines the utility of brief cognitive tests and neuropsychological testing (NPT) in the detection and diagnosis of mild cognitive impairment (MCI) and dementia. All patients presenting with cognitive complaints are recommended to have a brief screening test administered to document the presence and severity of memory/cognitive deficits. There is fair evidence to support the use of a range of new screening tests that can detect MCI and mild dementia with higher sensitivity (>or=80%) than the Mini-Mental State Exam (MMSE). NPT should be part of a clinically integrative approach to the diagnosis and differential diagnosis of dementia. It should be applied selectively to address specific clinical and diagnostic issues including: 1) The distinction between normal cognitive functioning in the aged, MCI and early dementia: there is fair evidence that NPT can document the presence of specific diagnostic criteria and provide additional useful information on the pattern of memory/cognitive impairment. 2) The evaluation of risk for Alzheimer disease (AD) or other types of dementia in persons with MCI: there is fair evidence that NPT measures or profiles can predict progression to dementia (predictive accuracy ranges from approximately 80 to 100%, sensitivities from 53 to 80%, and specificities from 67 to 99%). 3) DIFFERENTIAL DIAGNOSIS: There is fair evidence that NPT can complement clinical history and neuroimaging in determining the dementia etiology. Different dementia types have distinguishable NPT profiles though these may be stage-dependent, and increased sensitivity may be at the expense of specificity. 4) When NPT is part of a comprehensive assessment, which also entails clinical interviews and consideration of other clinical data, there is good evidence that it can contribute to management decisions in MCI and dementia, including the determination of retained and impaired cognitive abilities, their functional and vocational impact, and opportunities for cognitive rehabilitation.

Entities:  

Year:  2007        PMID: 19595951     DOI: 10.1016/j.jalz.2007.07.011

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  31 in total

1.  Do general practitioners recognize mild cognitive impairment in their patients?

Authors:  H Kaduszkiewicz; T Zimmermann; H Van den Bussche; C Bachmann; B Wiese; H Bickel; E Mösch; H-P Romberg; F Jessen; G Cvetanovska-Pllashniku; W Maier; S G Riedel-Heller; M Luppa; H Sandholzer; S Weyerer; M Mayer; A Hofmann; A Fuchs; H-H Abholz; M Pentzek
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

Review 2.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

3.  [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?]

Authors:  H Lohmann; F Kulessa; H Holling; A Johnen; S Reul; G Lueg; T Duning
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

4.  Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

5.  Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders.

Authors:  Elena Cecilia Rosca; Loai Albarqouni; Mihaela Simu
Journal:  Neuropsychol Rev       Date:  2019-08-22       Impact factor: 7.444

6.  Physical activity and trajectories in cognitive function: English Longitudinal Study of Ageing.

Authors:  Mark Hamer; Graciela Muniz Terrera; Panayotes Demakakos
Journal:  J Epidemiol Community Health       Date:  2018-02-06       Impact factor: 3.710

7.  Cognitive impairment in lacunar strokes: the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Raymond Costello; Leslie A McClure; Stephen L Holliday; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

8.  [Mini-Mental State Examination in geriatrics : An evaluation of diagnostic quality].

Authors:  S Beyermann; R H Trippe; A A Bähr; R Püllen
Journal:  Z Gerontol Geriatr       Date:  2013-12       Impact factor: 1.281

9.  Three-question dementia screening. Development of the Salzburg Dementia Test Prediction (SDTP).

Authors:  A K Kaiser; W Hitzl; B Iglseder
Journal:  Z Gerontol Geriatr       Date:  2014-11       Impact factor: 1.281

Review 10.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.